Bifidobacterium animalis subsp. lactis BB-12 and No Human Health Outcome Reported

• Untargeted metabolomic analysis uncovers metabolic variability of four Bifidobacterial strains for probiotic development.

  • 2025-01-31
  • Frontiers in microbiology 16
  • • Kailong Liu
    • Guoqiang Yao
    • Zhan Yang
    • Tian Huang
    • Lai-Yu Kwok
    • Heping Zhang

  • PubMed: 39959161
  • DOI: 10.3389/fmicb.2025.1522036

  2 Insights on

  • No Human Health Outcome Reported

  • Low evidence

  The abstract discusses metabolic differences among four selected Bifidobacterium strains (BB-69, Bbm-19, BX-18, and B8762) and does not mention Bifidobacterium animalis subsp. lactis BB-12 or any human/clinical health outcomes from consuming it.

  Effect

  Neutral

  Effect size

  Small

• Development of a Strain-Specific Detection and Quantification Method for Bifidobacterium animalis subsp. lactis HN019 Using WGS-SNP Analysis and qPCR.

  • 2025-07-07
  • Microorganisms 13(7)
  • • Da Mao
    • Lei Zhao
    • Bo Zhao
    • Hongbin Xu
    • Qinghe Zhang

  • PubMed: 40732105
  • DOI: 10.3390/microorganisms13071596

  6 Insights on

  • No Human Health Outcome Reported

  • Low evidence

  The provided abstract focuses on development of a strain-specific detection and quantification method for Bifidobacterium animalis subsp. lactis HN019... It does not describe observed health outcomes of consuming Bifidobacterium animalis subsp. lactis BB-12.

  Effect

  Neutral

  Effect size

  Small